Metformin as an anticancer drug: A Commentary on the metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides

Publisher: John Wiley & Sons Inc

E-ISSN: 2040-1124|6|5|516-518

ISSN: 2040-1116

Source: Journal Of Diabetes Investigation, Vol.6, Iss.5, 2015-09, pp. : 516-518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract